Literature DB >> 31037501

MiR-153 regulates cardiomyocyte apoptosis by targeting Nrf2/HO-1 signaling.

Xianting Zhu1, Yuling Zhao2, Wei Hou2, Ling Guo3.   

Abstract

MicroRNAs (miRNAs) play various roles in the regulation of human disease, including cardiovascular diseases. MiR-153 has been previously shown to be involved in regulating neuron survival during cerebral ischemia/reperfusion (I/R) injury. However, whether miR-153 is involved in I/R-induced cardiomyocyte apoptosis remains to be elucidated. In this study, we aimed to explore the role of miR-153 in the regulation of I/R-induced cardiomyocyte apoptosis and to investigate the miR-153-mediated molecular signaling pathway responsible for its effect on cardiomyocytes using an oxygen-glucose deprivation and reoxygenation (OGD/R) cellular model. We found that OGD/R treatment induced significant upregulation of miR-153 in cardiomyocytes causing reactive oxygen species (ROS) production and cell apoptosis signaling activation and subsequently leading to cardiomyocyte apoptosis. Suppression of miR-153 protected cardiomyocytes against OGD/R treatment. We further identified that nuclear factor-like 2 (Nrf2) is a functional target of miR-153. Nrf2/ heme oxygenase-1 (HO-1) signaling plays a critical role in miR-153 regulated OGD/R-induced cardiomyocyte apoptosis. Our study indicates that the inhibition of miR-153 or restoration of Nrf2 may serve as a potential therapeutic strategy for ischemia/reperfusion injury prevention.

Entities:  

Keywords:  Apoptosis; Cardiomyocytes; Ischemia/reperfusion; Nrf2; miR-153

Year:  2019        PMID: 31037501     DOI: 10.1007/s10577-019-09608-y

Source DB:  PubMed          Journal:  Chromosome Res        ISSN: 0967-3849            Impact factor:   5.239


  27 in total

1.  Suppression of AKT expression by miR-153 produced anti-tumor activity in lung cancer.

Authors:  Ye Yuan; Weijie Du; Ying Wang; Chaoqian Xu; Jinghao Wang; Yang Zhang; Huimin Wang; Jiaming Ju; Liang Zhao; Zhiguo Wang; Yanjie Lu; Benzhi Cai; Zhenwei Pan
Journal:  Int J Cancer       Date:  2014-08-07       Impact factor: 7.396

2.  MicroRNA-153 functions as a tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer cells.

Authors:  Jun Zhou; Ming Xie; Ying Shi; Baihua Luo; Guanghui Gong; Juanni Li; Junpu Wang; Wenjian Zhao; Yuan Zi; Xiaoying Wu; Jifang Wen
Journal:  Oncol Rep       Date:  2015-05-05       Impact factor: 3.906

3.  microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects.

Authors:  R Kannan Mutharasan; Varun Nagpal; Yoshihiko Ichikawa; Hossein Ardehali
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-12       Impact factor: 4.733

Review 4.  MicroRNAs in myocardial infarction.

Authors:  Reinier A Boon; Stefanie Dimmeler
Journal:  Nat Rev Cardiol       Date:  2014-12-16       Impact factor: 32.419

5.  Impact of miR-208 and its Target Gene Nemo-Like Kinase on the Protective Effect of Ginsenoside Rb1 in Hypoxia/Ischemia Injuried Cardiomyocytes.

Authors:  Xu Yan; Jianxun Liu; Hongjin Wu; Yuna Liu; Sidao Zheng; Chengying Zhang; Cui Yang
Journal:  Cell Physiol Biochem       Date:  2016-09-01

Review 6.  Toward microRNA-based therapeutics for heart disease: the sense in antisense.

Authors:  Eva van Rooij; William S Marshall; Eric N Olson
Journal:  Circ Res       Date:  2008-10-24       Impact factor: 17.367

Review 7.  The clinics of acute coronary syndrome.

Authors:  Gianfranco Cervellin; Gianni Rastelli
Journal:  Ann Transl Med       Date:  2016-05

8.  miR-153 regulates apoptosis and autophagy of cardiomyocytes by targeting Mcl-1.

Authors:  Yuhai Zou; Wenting Liu; Jinxia Zhang; Dingcheng Xiang
Journal:  Mol Med Rep       Date:  2016-05-19       Impact factor: 2.952

9.  Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.

Authors:  Gregory A Roth; Catherine Johnson; Amanuel Abajobir; Foad Abd-Allah; Semaw Ferede Abera; Gebre Abyu; Muktar Ahmed; Baran Aksut; Tahiya Alam; Khurshid Alam; François Alla; Nelson Alvis-Guzman; Stephen Amrock; Hossein Ansari; Johan Ärnlöv; Hamid Asayesh; Tesfay Mehari Atey; Leticia Avila-Burgos; Ashish Awasthi; Amitava Banerjee; Aleksandra Barac; Till Bärnighausen; Lars Barregard; Neeraj Bedi; Ezra Belay Ketema; Derrick Bennett; Gebremedhin Berhe; Zulfiqar Bhutta; Shimelash Bitew; Jonathan Carapetis; Juan Jesus Carrero; Deborah Carvalho Malta; Carlos Andres Castañeda-Orjuela; Jacqueline Castillo-Rivas; Ferrán Catalá-López; Jee-Young Choi; Hanne Christensen; Massimo Cirillo; Leslie Cooper; Michael Criqui; David Cundiff; Albertino Damasceno; Lalit Dandona; Rakhi Dandona; Kairat Davletov; Samath Dharmaratne; Prabhakaran Dorairaj; Manisha Dubey; Rebecca Ehrenkranz; Maysaa El Sayed Zaki; Emerito Jose A Faraon; Alireza Esteghamati; Talha Farid; Maryam Farvid; Valery Feigin; Eric L Ding; Gerry Fowkes; Tsegaye Gebrehiwot; Richard Gillum; Audra Gold; Philimon Gona; Rajeev Gupta; Tesfa Dejenie Habtewold; Nima Hafezi-Nejad; Tesfaye Hailu; Gessessew Bugssa Hailu; Graeme Hankey; Hamid Yimam Hassen; Kalkidan Hassen Abate; Rasmus Havmoeller; Simon I Hay; Masako Horino; Peter J Hotez; Kathryn Jacobsen; Spencer James; Mehdi Javanbakht; Panniyammakal Jeemon; Denny John; Jost Jonas; Yogeshwar Kalkonde; Chante Karimkhani; Amir Kasaeian; Yousef Khader; Abdur Khan; Young-Ho Khang; Sahil Khera; Abdullah T Khoja; Jagdish Khubchandani; Daniel Kim; Dhaval Kolte; Soewarta Kosen; Kristopher J Krohn; G Anil Kumar; Gene F Kwan; Dharmesh Kumar Lal; Anders Larsson; Shai Linn; Alan Lopez; Paulo A Lotufo; Hassan Magdy Abd El Razek; Reza Malekzadeh; Mohsen Mazidi; Toni Meier; Kidanu Gebremariam Meles; George Mensah; Atte Meretoja; Haftay Mezgebe; Ted Miller; Erkin Mirrakhimov; Shafiu Mohammed; Andrew E Moran; Kamarul Imran Musa; Jagat Narula; Bruce Neal; Frida Ngalesoni; Grant Nguyen; Carla Makhlouf Obermeyer; Mayowa Owolabi; George Patton; João Pedro; Dima Qato; Mostafa Qorbani; Kazem Rahimi; Rajesh Kumar Rai; Salman Rawaf; Antônio Ribeiro; Saeid Safiri; Joshua A Salomon; Itamar Santos; Milena Santric Milicevic; Benn Sartorius; Aletta Schutte; Sadaf Sepanlou; Masood Ali Shaikh; Min-Jeong Shin; Mehdi Shishehbor; Hirbo Shore; Diego Augusto Santos Silva; Eugene Sobngwi; Saverio Stranges; Soumya Swaminathan; Rafael Tabarés-Seisdedos; Niguse Tadele Atnafu; Fisaha Tesfay; J S Thakur; Amanda Thrift; Roman Topor-Madry; Thomas Truelsen; Stefanos Tyrovolas; Kingsley Nnanna Ukwaja; Olalekan Uthman; Tommi Vasankari; Vasiliy Vlassov; Stein Emil Vollset; Tolassa Wakayo; David Watkins; Robert Weintraub; Andrea Werdecker; Ronny Westerman; Charles Shey Wiysonge; Charles Wolfe; Abdulhalik Workicho; Gelin Xu; Yuichiro Yano; Paul Yip; Naohiro Yonemoto; Mustafa Younis; Chuanhua Yu; Theo Vos; Mohsen Naghavi; Christopher Murray
Journal:  J Am Coll Cardiol       Date:  2017-05-17       Impact factor: 24.094

Review 10.  The Role of Nrf2 in Cardiovascular Function and Disease.

Authors:  Sandro Satta; Ayman M Mahmoud; Fiona L Wilkinson; M Yvonne Alexander; Stephen J White
Journal:  Oxid Med Cell Longev       Date:  2017-09-14       Impact factor: 6.543

View more
  10 in total

Review 1.  Recent Advances in the Role of Nuclear Factor Erythroid-2-Related Factor 2 in Spinal Cord Injury: Regulatory Mechanisms and Therapeutic Options.

Authors:  Tianqi Jiang; Yongxiong He
Journal:  Front Aging Neurosci       Date:  2022-06-10       Impact factor: 5.702

2.  Downregulation of RKIP promotes radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1 axis via downregulating miR-450b-5p.

Authors:  Wei Huang; Guangqing Shi; Zhong Yong; Jian Li; Juan Qiu; Yan Cao; Yongfeng Zhao; Li Yuan
Journal:  Cell Death Dis       Date:  2020-07-06       Impact factor: 8.469

3.  Gossypol Acetic Acid Attenuates Cardiac Ischemia/Reperfusion Injury in Rats via an Antiferroptotic Mechanism.

Authors:  Jian-Hong Lin; Kun-Ta Yang; Pei-Ching Ting; Yu-Po Luo; Ding-Jyun Lin; Yi-Shun Wang; Jui-Chih Chang
Journal:  Biomolecules       Date:  2021-11-10

Review 4.  The Antioxidant Transcription Factor Nrf2 in Cardiac Ischemia-Reperfusion Injury.

Authors:  Ana Mata; Susana Cadenas
Journal:  Int J Mol Sci       Date:  2021-11-03       Impact factor: 5.923

Review 5.  Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-coding RNAs.

Authors:  Pieterjan Ginckels; Paul Holvoet
Journal:  Yale J Biol Med       Date:  2022-03-31

6.  Interference with megalin expression/endocytic function by montelukast mitigates gentamicin nephrotoxicity: Downregulation of ClC-5 expression.

Authors:  Amany A Azouz; Dina A Hanna; Ali A Abo-Saif; Basim Anwar Shehata Messiha
Journal:  Saudi Pharm J       Date:  2022-01-04       Impact factor: 4.562

7.  RNA sequencing-based identification of the regulatory mechanism of microRNAs, transcription factors, and corresponding target genes involved in vascular dementia.

Authors:  Kaiyue Zhao; Li Zeng; Zhongdi Cai; Mimin Liu; Ting Sun; Zhuorong Li; Rui Liu
Journal:  Front Neurosci       Date:  2022-09-20       Impact factor: 5.152

Review 8.  Comprehensive overview of Nrf2-related epigenetic regulations involved in ischemia-reperfusion injury.

Authors:  Jun Zhang; Wanqian Pan; Yue Zhang; Mingyue Tan; Yunfei Yin; Yuanmei Li; Lei Zhang; Lianhua Han; Jiaxiang Bai; Tingbo Jiang; Hongxia Li
Journal:  Theranostics       Date:  2022-09-11       Impact factor: 11.600

9.  miR-155 Knockdown Protects against Cerebral Ischemia and Reperfusion Injury by Targeting MafB.

Authors:  Li Zhang; Chao Liu; Chao Huang; Xiaohui Xu; Junfang Teng
Journal:  Biomed Res Int       Date:  2020-01-21       Impact factor: 3.411

Review 10.  NRF2-Related Epigenetic Modifications in Cardiac and Vascular Complications of Diabetes Mellitus.

Authors:  Jie Wang; Mengjie Xiao; Jie Wang; Shudong Wang; Jingjing Zhang; Yuanfang Guo; Yufeng Tang; Junlian Gu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-25       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.